The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and
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The blood-brain barrier (BBB) is composed of tightly bound endothelial cells (ECs) and perivascular astrocytes that regulate central nervous system (CNS) homeostasis. We showed that astrocytes secrete Sonic hedgehog and that BBB ECs express Hedgehog (Hh) receptors, which together promote BBB formation and integrity during embryonic development and adulthood. Using pharmacological inhibition and genetic inactivation of the Hh signaling pathway in ECs, we also demonstrated a critical role of the Hh pathway in promoting the immune quiescence of BBB ECs by decreasing the expression of proinflammatory mediators and the adhesion and migration of leukocytes, in vivo and in vitro. Overall, the Hh pathway provides a barrier-promoting effect and an endogenous anti-inflammatory balance to CNS-directed immune attacks, as occurs in multiple sclerosis.
T he blood-brain barrier (BBB) confers homeostasis to the central nervous system (CNS) and limits the entry of blood-borne molecules and circulating leukocytes. The BBB is composed of specialized endothelial cells (ECs) held together by multiprotein complexes known as junctional proteins (1, 2) . Astrocytes, which are closely apposed to the CNS vasculature, help maintain BBB integrity and immune quiescence through contact-dependent mechanisms and by releasing soluble factors (2) (3) (4) (5) . BBB disruption is a central and early feature of multiple sclerosis (MS) that allows leukocytes to enter the CNS, leading to demyelination and neuronal damage (6) (7) (8) .
The Hedgehog (Hh) pathway is involved in embryonic morphogenesis, neuronal guidance, and angiogenesis (9, 10) . In adult tissues, it participates in vascular proliferation, differentiation, and tissue repair (11) (12) (13) . CNS morphogenic events are primarily associated with Sonic Hh (Shh) signaling (14) (15) (16) . Secreted Shh binds and inactivates the receptor Patched-1 (Ptch-1), allowing activation of Smoothened (Smo), which then induces target genes through the Gli family of transcription factors (17) . Previous studies have implicated Shh signaling in MS and its animal model (18, 19) . We therefore explored whether the Hh pathway contributes to the maintenance of BBB functions, including its immune quiescence.
mRNA and protein analyses demonstrated expression of Shh and its 45-kD uncleaved precursor in human fetal astrocytes (HFAs) but not on primary cultures of BBB ECs ( fig. S1, A and B) . In contrast, the highest levels of Ptch-1 and Smo expression were observed in BBB ECs (fig. S1, A and B). Essential to Hh signaling is the autocatalytic cleavage of the 45-kD Shh protein to yield a~19-kD active form, which was present in astrocyte-conditioned media (ACM) (fig. S1B). We detected Shh in human and mouse astrocytes in vitro and in situ but not in ECs or pericytes (fig. S1, C to H). Conversely, Ptch-1 and Smo were detected on cultured BBB ECs and in situ in human and mouse CNS ECs, but not on astrocytes or pericytes ( fig. S1, C to H) . Therefore, our data suggest that the Hh pathway is used by perivascular astrocytes to communicate with BBB ECs.
To determine whether astrocyte-secreted Shh influences BBB function, the transendothelial electrical resistance (TEER) and permeability of human BBB ECs were evaluated under conditions stimulating or abrogating the Hh pathway. We found that human recombinant Shh (hrShh) significantly increased TEER and decreased dextran 3-kD clearance, as well as permeability to 14 C-sucrose and bovine serum albumin-fluorescein isothiocyanate (BSA-FITC) (Fig. 1, A to D) . This effect was comparable to the one induced by ACM, and the response of BBB ECs to Shh did not affect EC proliferation ( fig. S2A) . Activation of the Hh pathway was responsible for the barrierpromoting effect of ACM, because BBB ECs treated with the Smo agonist purmorphamine reproduced the effect of hrShh, whereas Smo antagonists cyclopamine (Fig. 1, A to D) and SANT-1 ( fig. S2B ) reversed the effect of ACM. These data reflect a combination of changes in TEER, paracellular permeability, and inducible transport mechanisms, suggesting that Hh ligands could affect both processes, possibly through the regulation of junctional proteins.
Hh activation is associated with a restrictive permeability, therefore we determined the expression of the transcription factors Gli-1 and sex-determining region Y-box-18 (SOX-18), an important regulator of junctional protein expression (i.e., claudin-5) and barrier formation (20) . The number of BBB ECs expressing Gli-1 increased upon Hh activation, as compared to untreated cells. However, cyclopamine reduced the expression of Gli-1 induced by ACM (Fig. 1, E and F). hrShh stimulation and ACM significantly up-regulated Hip, Gli-1, and SOX-18 transcription ( Fig. 1G and fig. S2C ). SOX-18 expression was maximal 2 hours after Gli-1 activation, confirming that SOX-18 is regulated by the Hh pathway, possibly through Gli-1.
To further confirm the role of the Hh pathway in maintaining BBB properties in vivo, we injected mice with cyclopamine and studied the extent of BBB leakage. Cyclopamine induced acute BBB disruption (6 hours after injection), as demonstrated by the increased extravasation of exogenous dextran and endogenous fibrinogen (Fig. 1, H and I ). Cyclopamine treatment also REPORTS on February 2, 2012 www.sciencemag.org induced extravasation of perivascular bloodderived leukocytes (Fig. 1H and fig. S2D ), without inducing hemorrhage. Thus, the Hh pathway is important in the maintenance of adult BBB function, and disruption of Smo-dependent signaling leads to acute BBB breakdown.
Because an active Hh pathway promotes BBB properties, we investigated whether the expression of junctional proteins in human BBB ECs is dependent on the astrocyte-derived Shh signal. mRNAs encoding occludin and claudin-5 were up-regulated in response to Hh signaling ( Fig. 2A) . Protein analyses from BBB ECs treated with ACM revealed a moderate increase in the expression of occludin, junctional adhesion molecule-A (JAM-A), VE-cadherin, claudin-3, and claudin-5 ( Fig. 2B) , whereas cyclopamine and SANT-1 decreased the expression of these proteins (Fig. 2B  and fig. S2E ). The effect of Shh on junctional protein expression was also studied in Shh-deficient mice (Shh −/− ). These animals exhibit embryonic lethality, and embryos were harvested between embryonic day 11 (E11) and E13. 5 (14) , at the time of gradual BBB development (21) . Junctional strands were visible in brain capillaries from E13.5 wild-type (WT) mice (fig. S3A) ; however, the expression of junctional proteins per vessel was significantly lower in Shh −/− mice ( fig. S3 , A and B) and did not affect the total number of blood vessels in the developing brain ( fig. S3C ).
To specifically assess the role of the Hh pathway in ECs, we selectively deleted a conditional allele of the signal transducer Smo from ECs using a Tie2-Cre driver (Tie2-Cre; Smo c/c ) ( fig. S4 , A to D). Deletion of Smo in ECs was associated with a significant increase in BBB permeability to the endogenous serum proteins fibrinogen, immunoglobulins, and apolipoprotein B at E14 and postnatal day 19 (P19) (Fig. 2C and figs. S4E and S5A) and to the exogenous tracers in 8-week-old adult mice (figs. S5, B to D, and S6A). The plasma protein leakage into the CNS correlated with a significant decrease in the expression of occludin, claudin-3, claudin-5, ZO1, and p120 ( Fig. 2C and figs. S4E and S6B) and with a compromised base- S6,  C and D) . In WT developing brains, the lack of serum protein extravasation in parenchymal vessels confirmed the BBB restrictiveness previously reported during embryogenesis (22, 23) . Moreover, astrocyte association with the BBB was considerably reduced at P19 (Fig. 2C ) and resulted in perivascular gliosis in adult mice ( fig.   S5D ). Thus, the genetic neutralization of the Hh pathway in CNS endothelium resulted in lower expression of junctional proteins and the accumulation of plasma proteins in the CNS, which are hallmarks of a perturbed and compromised BBB. 
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Under normal conditions, the restrictiveness of the CNS to immune responses is in part attributable to the BBB. To determine the role of Shh in this process, we studied its effect on the expression of chemoattractants and cell adhesion molecules (CAMs). Hh activation in human BBB ECs drastically decreased the secretion of the chemokines CXCL8/interleukin-8 (IL-8) and CCL2/MCP-1, whereas cyclopamine abrogated this effect (Fig. 3A) . Under basal conditions, primary cultures of BBB ECs expressed intercellular adhesion molecule-1 (ICAM-1) (Fig. 3B) . Stimulating Hh signaling significantly reduced the percentage and levels of ICAM-1 expression in these cells (Fig. 3B and fig. S7A ), whereas cyclopamine reverted this effect (Fig. 3B) . In contrast, neither Shh nor ACM affected the expression of the a4b1 integrin ligands vascular cell adhesion molecule-1 (VCAM-1) or CS-1 ( fig. S7, B and C) . We next assessed CD4 + T cell adhesion to, and migration across, Hh-activated BBB ECs. Adhesion of unstimulated (ex vivo) human CD4 + T cells was significantly reduced after 1 and 2 hours in Hhactivated BBB ECs (Fig. 3C and fig. S7D , respectively) and was increased by 45% with cyclopamine treatment (Fig. 3C) . Likewise, ACM, hrShh, and purmorphamine significantly reduced CD4 + T cell transmigration across BBB ECs grown in Hh-stimulating conditions (Fig. 3D ) without affecting T cell proliferation ( fig. S7E) .
To further characterize the role of the Hh pathway in inducing CNS immune quiescence, we evaluated the effect of Hh activation on T helper 1 (T H 1) and T H 17 cells, which are known to participate in neuroinflammatory processes such as MS (24, 25) . Ex vivo monocytes and T cells can respond to Shh as they express Ptch-1, Smo, and Gli-1 ( fig. S7F ). Human CD4 + T cells polarized into T H 1 and T H 17 lymphocytes ( fig. S8A) (24) adhered significantly less to BBB ECs when polarized in the presence of Shh (Fig. 3E) , whereas the adhesion of T H 2 cells was significantly enhanced. To elucidate the effect of Shh on the adhesion capacity of T H cells, we studied the expression of molecules known to participate in leukocyte migration through the BBB in MS (7, (26) (27) (28) . Shh decreased the expression of CD6 on T H 17 cells, increased expression of CD6 and VLA-4 on T H 2, and reduced interferon-g (IFN-g) production by T H 1 cells (fig. S8, B to E) . In contrast, the levels of LFA-1, VLA-4, and IL-17 remained similar to the control in T H 17 cells, whereas expression of CD6, LFA-1, and VLA-4 were unaffected in T H 1 cells (fig. S8F ). Downregulation of CD6 and IFN-g was confirmed in T H 1 and T H 17 cells expanded in the presence of ACM and treated with a functional blocking antibody to Shh (fig. S8, G and H) .
Given the immune-modulating effect seen on BBB components in Hh-activating conditions, we assessed the influence of Hh pathway blockade in experimental autoimmune encephalomyelitis (EAE), the animal model of MS, by repeated injections of the Hh pathway antagonist GDC-0449. Hh antagonism significantly increased disease severity (Fig. 3F and fig. S9A ), the extent of demyelination (Fig. 3G) , the amount of leukocytes accumulating in the CNS (Fig. 3H) , and the production of IFN-g and IL-17 in T cells infiltrating the CNS (Fig. 3I) . The magnitude of T cell activation in the GDC-0449-treated animals was unique to the CNS compartment, because the degree of T cell activation in the periphery did not differ between both groups ( fig. S9, B and C) . Collectively, these data support an endogenous We next evaluated the effect of an inflammatory environment on the expression of Hh components in the cellular elements of the BBB. HFAs inflamed with tumor necrosis factor (TNF) and IFN-g increased Shh expression as compared to a control (Fig. 4A) , whereas BBB ECs grown in ACM and treated with TNF and IFN-g increased their expression of Ptch-1 and Smo (Fig.  4B) . To further support these findings, the expression of Shh, Ptch-1, and Smo was also determined in the human CNS. In control brain tissue and in normal-appearing white matter (NAWM) of MS patients, astrocyte endfeet surrounding parenchymal vessels displayed Shh immunoreactivity, and BBB ECs expressed Smo and Ptch-1 (Fig. 4, C and D, and fig. S9D ). Shh immunoreactivity, however, was strikingly enhanced in hypertrophic astrocytes throughout active demyelinating MS lesions (Fig. 4, C and D) . In NAWM, Ptch-1 expression was mainly restricted to ECs surrounded by astrocytic endfeet (Fig. 4D) , whereas in active MS lesions, Ptch-1 expression increased on ECs and was also detected on infiltrating leukocytes (Fig. 4D ). Smo expression in NAWM was predominant in the vasculature, and although Smo was detected in macrophages and brain ECs in active lesions (fig S9D) , no significant up-regulation was observed. Finally, Gli-1 was found in the cytoplasm of ECs in NAWM, whereas in active MS lesions, Gli-1 was detected in the nucleus of both ECs and infiltrating leukocytes (Fig. 4D) . These data suggest that upon inflammatory stimulation, astrocyte-secreted Shh induced the expression of Hh receptors in BBB ECs, which led to the up-regulation and translocation of the Hh transcription factor Gli-1 into the nucleus of BBB ECs.
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